T Kzia Us48669g1058 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

SYDNEY, June 3, 2021 /PRNewswire/ Kazia Therapeutics Limited , an oncology-focused drug development company, announced today that its CEO, Dr James Garner, will be presenting virtually at the. | June 3, 2021

New south walesUnited statesKazia therapeutics limitedPrnewswire kazia therapeutics limitedKazia therapeuticsTherapeutics limitedSequire virtual eventsOrphan drug designationFast track designationRare pediatric disease designationOrphan designationTexas rangersWorld seriesKazia therapeutics limited stock exchangePress releaseT kzia us48669g1058